TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

November 1, 2025

Study Completion Date

December 1, 2026

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

RADIATION

Radiotherapy

Simultaneously optimizing the target, dosage, and synchronized drugs for radiotherapy.

Trial Locations (1)

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER